Literature DB >> 26660111

The Impact of UNC5C Genetic Variations on Neuroimaging in Alzheimer's Disease.

Jia-Hao Sun1, Hui-Fu Wang2, Xi-Chen Zhu2, Wan-Jiang Yu3, Chen-Chen Tan1, Teng Jiang4, Meng-Shan Tan1, Lan Tan5,6, Jin-Tai Yu7,8,9.   

Abstract

UNC5C, which is a transmembrane receptor for netrin-1 to trigger the apoptosis, has been confirmed as a new risk factor for Alzheimer's disease (AD) recently. However, there is lack of the evidence on the brain structure associated with the polymorphisms of UNC5C in AD. The objective of this study is to investigate the influence of UNC5C loci on the neuroimaging of strategic regions of AD. In 812 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset, we explored the genotypes of UNC5C loci in the volumes of the hippocampus, parahippocampal gyrus, posterior cingulate gyrus, middle temporal and precuneus, and the thickness of the entorhinal cortex which are measured by magnetic resonance imaging (MRI). We also investigated the atrophy rate of above structures influenced by UNC5C loci using the longitudinal data. UNC5C loci were associated with the volume of right middle temporal (rs34585936 Pc = 0.0031). Meanwhile, the polymorphisms of UNC5C loci could alter the atrophy rate of strategic regions especially the left hippocampus (rs72672784 Pc = 0.0090; rs13120458 Pc = 0.0434; rs34875919 Pc = 0.0434) and right precuneus (rs72672784 Pc = 0.0068; rs2001246 Pc = 0.0055; rs74690179 Pc = 0.0055). UNC5C genotypes were significantly associated with the volume of the middle temporal on MRI; meanwhile, UNC5C loci could alter the atrophy of strategic regions of AD such as the hippocampus and precuneus. And the above effects of polymorphisms of UNC5C were more obvious in the population with the impaired cognition than those with the normal cognition.

Entities:  

Keywords:  ADNI; Alzheimer’s disease; Biomarker; Neuroimaging; UNC5C

Mesh:

Substances:

Year:  2015        PMID: 26660111     DOI: 10.1007/s12035-015-9589-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  37 in total

Review 1.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

2.  R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.

Authors:  Olena Korvatska; James B Leverenz; Suman Jayadev; Pamela McMillan; Irina Kurtz; Xindi Guo; Malia Rumbaugh; Mark Matsushita; Santhosh Girirajan; Michael O Dorschner; Kostantin Kiianitsa; Chang-En Yu; Zoran Brkanac; Gwenn A Garden; Wendy H Raskind; Thomas D Bird
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

3.  Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Authors:  D P Devanand; G Pradhaban; X Liu; A Khandji; S De Santi; S Segal; H Rusinek; G H Pelton; L S Honig; R Mayeux; Y Stern; M H Tabert; M J de Leon
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

4.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

5.  Variants in the netrin-1 receptor UNC5C prevent apoptosis and increase risk of familial colorectal cancer.

Authors:  Marie-May Coissieux; Jerneja Tomsic; Marie Castets; Heather Hampel; Sari Tuupanen; Nadine Andrieu; Ilene Comeras; Youenn Drouet; Christine Lasset; Sandya Liyanarachchi; Laetitia Mazelin; Alain Puisieux; Jean-Christophe Saurin; Jean-Yves Scoazec; Qing Wang; Lauri Aaltonen; Stephan M Tanner; Albert de la Chapelle; Agnès Bernet; Patrick Mehlen
Journal:  Gastroenterology       Date:  2011-09-03       Impact factor: 22.682

6.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 7.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

8.  Differential aging of the medial temporal lobe: a study of a five-year change.

Authors:  N Raz; K M Rodrigue; D Head; K M Kennedy; J D Acker
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

9.  Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.

Authors:  Rachael I Scahill; Jonathan M Schott; John M Stevens; Martin N Rossor; Nick C Fox
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

10.  Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China.

Authors:  Bin Jiao; Xiaoyan Liu; Beisha Tang; Lihua Hou; Lin Zhou; Fufeng Zhang; Yafang Zhou; Jifeng Guo; Xinxiang Yan; Lu Shen
Journal:  Neurobiol Aging       Date:  2014-05-01       Impact factor: 4.673

View more
  9 in total

Review 1.  The role of UNC5C in Alzheimer's disease.

Authors:  Quan Li; Bai-Ling Wang; Fu-Rong Sun; Jie-Qiong Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 2.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

Review 3.  The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.

Authors:  Seda Sirin; Serap Nigdelioglu Dolanbay; Belma Aslim
Journal:  J Neural Transm (Vienna)       Date:  2022-04-16       Impact factor: 3.850

4.  Hyperexpressed Netrin-1 Promoted Neural Stem Cells Migration in Mice after Focal Cerebral Ischemia.

Authors:  Haiyan Lu; Xiaoyan Song; Feng Wang; Guodong Wang; Yuncheng Wu; Qiaoshu Wang; Yongting Wang; Guo-Yuan Yang; Zhijun Zhang
Journal:  Front Cell Neurosci       Date:  2016-09-30       Impact factor: 5.505

5.  Whole genome sequence analyses of brain imaging measures in the Framingham Study.

Authors:  Chloé Sarnowski; Claudia L Satizabal; Charles DeCarli; Achilleas N Pitsillides; L Adrienne Cupples; Ramachandran S Vasan; James G Wilson; Joshua C Bis; Myriam Fornage; Alexa S Beiser; Anita L DeStefano; Josée Dupuis; Sudha Seshadri
Journal:  Neurology       Date:  2017-12-27       Impact factor: 9.910

6.  A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients.

Authors:  Yan Liu; Dong Yan Zhu; Hong Jian Xing; Yi Hou; Yan Sun
Journal:  J Biol Res (Thessalon)       Date:  2020-05-19       Impact factor: 1.889

7.  Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.

Authors:  Ana Macedo; Carlos Gómez; Miguel Ângelo Rebelo; Jesús Poza; Iva Gomes; Sandra Martins; Aarón Maturana-Candelas; Víctor Gutiérrez-de Pablo; Luis Durães; Patrícia Sousa; Manuel Figueruelo; María Rodríguez; Carmen Pita; Miguel Arenas; Luis Álvarez; Roberto Hornero; Alexandra M Lopes; Nádia Pinto
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Netrin-1 receptor UNC5C cleavage by active δ-secretase enhances neurodegeneration, promoting Alzheimer's disease pathologies.

Authors:  Guiqin Chen; Seong Su Kang; Zhihao Wang; Eun Hee Ahn; Yiyuan Xia; Xia Liu; Ivette M Sandoval; Fredric P Manfredsson; Zhaohui Zhang; Keqiang Ye
Journal:  Sci Adv       Date:  2021-04-16       Impact factor: 14.957

Review 9.  Roles and Mechanisms of Axon-Guidance Molecules in Alzheimer's Disease.

Authors:  Lei Zhang; Zhipeng Qi; Jiashuo Li; Minghui Li; Xianchao Du; Shuang Wang; Guoyu Zhou; Bin Xu; Wei Liu; Shuhua Xi; Zhaofa Xu; Yu Deng
Journal:  Mol Neurobiol       Date:  2021-03-05       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.